Monocyte chemoattractant protein 1 (MCP- 1) in temporal arteritis and polymyalgia rheumatica

Annals of the Rheumatic Diseases

Volumn 59, Issue 10, 2000, Pages 775-780

  Ellingsen, T ^a   Elling, P ^b   Olson, A ^c   Elling, H ^c   Baandrup, U ^a   Matsushima, K ^a   Deleuran, B ^a   Stengaard Pedersen, Kristian ^a,d  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b RANDERS REGIONAL HOSPITAL   (Denmark)

^c VIBORG HOSPITAL   (Denmark)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ADVENTITIA; AGED; ARTERY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GIANT CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTIMA; MALE; MONONUCLEAR CELL; MUSCLE CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RHEUMATIC POLYMYALGIA; SMOOTH MUSCLE; TEMPORAL ARTERITIS; VASA VASORUM;

ADULT; AGED; AGED, 80 AND OVER; BLOOD SEDIMENTATION; CASE-CONTROL STUDIES; CD4-CD8 RATIO; CHEMOKINE CCL2; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBINS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; POLYMYALGIA RHEUMATICA; TEMPORAL ARTERIES; TEMPORAL ARTERITIS;

EID: 0033770644     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.10.775     Document Type: Article

References (26)

1. 1 Mallya RK, Hind CR, Berry H, Pepys MB. Serum C-reactive protein in polymyalgia rheumatica. A prospective serial study. Arthritis Rheum 1985;28:383-7.
2. 2 Roche NE, Fulbright JW, Wagner AD, Hunder GG, Goronzy JJ, Weyand CM. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 1993;36:1286-94.
3. 3 Salvarani C, Boiardi L, Macchioni P, Casadei Maidini M, Mancini R, Beltrandi E, et al. Serum soluble CD4 and CD8 levels in polymyalgia rheumatica. J Rheumatol 1994;21: 1865-9.
4. 4 Dasgupta B, Duke O, Timms AM, Pitzalis C, Panayi GS. Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 1989;48:307-11.
5. 5 Salvarani C, Macchioni P, Boiardi L, Rossi F, Casadei Maldini M, Mancini R. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations. J Rheumatol 1992;19:1100-6.
6. 6 Elling H, Elling P. Decreased level of suppressor/cytotoxic T cells (OKT8+) in polymyalgia rheumatica and temporal arteritis: relation to disease activity. J Rheumatol 1985;12: 306-9.
7. 7 Boiardi L, Salvarani C, Macchioni P, Casadei MM, Mancini R, Beltrandi E, et al. CD8 lymphocyte subsets in active polymyalgia rheumatica: comparison with elderly-onset and adult rheumatoid arthritis and influence of prednisone therapy. Br J Rheumatol 1996;35:642-8.
8. 8 Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 1994;121: 484-91.
9. 9 Valente AJ, Graves DT, Vialle Valentin CE, Delgado R, Schwartz CJ. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry 1988;27:4162-8.
10. 10 Berliner JA, Territo M, Almada L, Carter A, Shafonsky E, Fogelman AM. Monocyte chemotactic factor produced by large vessel endothelial cells in vitro. Arteriosclerosis 1986; 6:254-8.
11. 11 Deleuran M, Buhl L, Ellingsen T, Harada A, Larsen CG, Matsushima K, et al. Localization of monocyte chemotactic and activating factor (MCAF/MCP-1) in psoriasis. J Dermatol Sci 1996;13:228-36.
12. 12 Elling P, Olsson AT, Elling H. Reduced CD8+ T-cell concentration in peripheral blood of patients with carotid artery stenosis: relation to arteritis temporalis. Br J Rheumatol 1996;35:649-51.
13. 13 Nordborg E, Nordborg C, Bengtsson BA. Giant cell arteritis. Curr Opin Rheumatol 1992;4:23-30.
14. 14 Sica A, Wang JM, Colotta F, Dejana E, Mantovani A, Oppenheim JJ, et al. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J Immunol 1990;144:3034-8.
15. 15 Rollins BJ, Yoshimura T, Leonard EJ, Pober JS. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol 1990; 136:1229-33.
16. 16 Lowenstein MB, Bridgeford PH, Vasey FB, Germain BF, Espinoza LR. Increased frequency of HLA-DR3 and DR4 in polymyalgia rheumatica-giant cell arteritis. Arthritis Rheum 1983;26:925-7.
17. 17 Wang JM, Sica A, Peri G, Walter S, Padura IM, Libby P, et al. Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. Arterioscler Thromb 1991;11:1166-74.
18. 18 Wenzel UO, Fouqueray B, Grandaliano G, Kim YS, Karamitsos C, Valente AJ, et al. Thrombin regulates expression of monocyte chemoattractant protein-1 in vascular smooth muscle cells. Circ Res 1995;77:503-9.
19. 19 Hayes IM, Jordan NJ, Towers S, Smith G, Paterson JR, Earnshaw JJ, et al. Human vascular smooth muscle cells express receptors for CC chemokines. Arterioscler Thromb Vasc Biol 1998;18:397-403.
20. 20 Reinecke RD, Kuwabara T. Temporal arteritis. I. Smooth muscle cell involvement. Arch Ophthalmol 1969;82:446-53.
21. 21 Takeya M, Yoshimura T, Leonard EJ, Takahashi K. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol 1993;24:534-9.
22. 22 Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991;88:1121-7.
23. 23 Ida N, Sakurai S, Kawano G. Detection of monocyte chemotactic and activating factor (MCAF) in normal blood and urine using a sensitive ELISA. Cytokine 1994;6: 32-9.
24. 24 Inadera H, Egashira K, Takemoto M, Ouchi Y, Matsushima K. Increase in circulating levels of monocyte chemoattractant protein 1 with aging. J Interferon Cytokine Res 1999;19:1179-82.
25. 25 Ellis ME, Ralston S. The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome. Ann Rheum Dis 1983;42:168-70.
26. 26 Hashimoto S, Nakayama T, Gon Y, Hata N, Koura T, Maruoka S, et al. Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1alpha (MIP-1alpha) levels with disease activity and clinical course of sarcoidosis. Clin Exp Immunol 1998;111:604-10.